Edition:
United States

Organovo Holdings Inc (ONVO.OQ)

ONVO.OQ on NASDAQ Stock Exchange Global Market

1.76USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$1.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
179,747
52-wk High
$3.19
52-wk Low
$0.91

Chart for

About

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products,... (more)

Overall

Beta: 2.89
Market Cap(Mil.): $189.53
Shares Outstanding(Mil.): 110.84
Dividend: --
Yield (%): --

Financials

  ONVO.OQ Industry Sector
P/E (TTM): -- 223.30 32.53
EPS (TTM): -0.36 -- --
ROI: -62.86 -8.07 12.63
ROE: -63.61 -10.87 14.50

BRIEF-Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement

* ORGANOVO DIVISION SAMSARA SCIENCES ANNOUNCES MULTI-YEAR SUPPLY AGREEMENT WITH LONZA BIOSCIENCE SOLUTIONS

Mar 26 2018

BRIEF-Organovo Holdings- Entered Sales Agreement Where Co May Offer, Sell Shares In 'At Market' Sales Transactions With Offering Price Of Up To $50 Million

* ORGANOVO HOLDINGS- ENTERED SALES AGREEMENT WHERE CO MAY OFFER, SELL SHARES IN 'AT MARKET' SALES TRANSACTIONS WITH OFFERING PRICE OF UP TO $50 MILLION

Mar 16 2018

BRIEF-Organovo Holdings Files For Mixed Shelf Offering Of Up To $100 Mln

* ORGANOVO HOLDINGS INC FILES FOR MIXED SHELF OFFERING OF UP TO $100 MILLION - SEC FILING Source text (http://bit.ly/2EQ7FuR) Further company coverage:

Feb 08 2018

BRIEF-Organovo Reports Q3 Loss Per Share Of $0.07

* ORGANOVO ANNOUNCES FISCAL THIRD-QUARTER 2018 RESULTS; COMPANY UPDATES FULL-YEAR FISCAL 2018 OUTLOOK

Feb 08 2018

BRIEF-Organovo Receives Orphan Designation From U.S. FDA For 3D Bioprinted Therapeutic Liver Tissue

* ORGANOVO RECEIVES ORPHAN DESIGNATION FROM U.S. FDA FOR 3D BIOPRINTED THERAPEUTIC LIVER TISSUE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY Source text for Eikon: Further company coverage:

Dec 26 2017

Earnings vs. Estimates